1,935 Shares in ARK Genomic Revolution ETF (BATS:ARKG) Bought by Naples Money Management LLC

Naples Money Management LLC bought a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,935 shares of the company’s stock, valued at approximately $63,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Operose Advisors LLC bought a new position in ARK Genomic Revolution ETF during the third quarter worth $25,000. Stephens Consulting LLC bought a new position in ARK Genomic Revolution ETF during the third quarter worth $28,000. High Net Worth Advisory Group LLC boosted its stake in ARK Genomic Revolution ETF by 80.9% during the first quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock worth $51,000 after buying an additional 500 shares in the last quarter. Allworth Financial LP boosted its stake in ARK Genomic Revolution ETF by 65.3% during the third quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock worth $40,000 after buying an additional 563 shares in the last quarter. Finally, BKM Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the fourth quarter worth $78,000.

ARK Genomic Revolution ETF Price Performance

ARKG traded down $0.23 during trading on Friday, reaching $23.32. 3,427,540 shares of the company’s stock were exchanged. The firm has a fifty day moving average of $28.81 and a 200 day moving average of $28.43.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.